{"symbol":"PFE","fiscalQuarter":"Q4-2016","reportDate":"2017-01-31","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q4-2016","postBrief":{"headline":"Pfizer Misses on EPS, Stock Up 1.34%","keyNumbers":[{"metric":"EPS","actual":"$0.47","expected":"N/A","surprise":"-5.24%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing challenges in the market.","They emphasized their commitment to innovation and pipeline development."],"summary":"Overall, management conveyed a cautious outlook, acknowledging the competitive landscape while focusing on future growth opportunities."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report shows a slight miss on EPS, which may raise concerns among investors about profitability. However, the stock rose by 1.34%, likely due to positive sentiment around their ongoing projects and future growth potential. Investors may be encouraged by management's focus on innovation despite the EPS miss.","metaDescription":"Pfizer Inc (PFE) Q4 2016 earnings: EPS missed expectations. Stock up 1.34%. Full breakdown."}}